DK1000027T3 - Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne - Google Patents

Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne

Info

Publication number
DK1000027T3
DK1000027T3 DK98937576T DK98937576T DK1000027T3 DK 1000027 T3 DK1000027 T3 DK 1000027T3 DK 98937576 T DK98937576 T DK 98937576T DK 98937576 T DK98937576 T DK 98937576T DK 1000027 T3 DK1000027 T3 DK 1000027T3
Authority
DK
Denmark
Prior art keywords
carbazolyloxy
methoxyphenoxy
ethylamino
propanol
preparation
Prior art date
Application number
DK98937576T
Other languages
Danish (da)
English (en)
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK1000027T3 publication Critical patent/DK1000027T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK98937576T 1997-07-22 1998-07-18 Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne DK1000027T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
PCT/EP1998/004475 WO1999005105A1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
DK1000027T3 true DK1000027T3 (da) 2003-07-21

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98937576T DK1000027T3 (da) 1997-07-22 1998-07-18 Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne

Country Status (31)

Country Link
EP (2) EP0893440A1 (cs)
JP (1) JP2001510824A (cs)
KR (1) KR100336229B1 (cs)
CN (1) CN1125047C (cs)
AR (1) AR015133A1 (cs)
AT (1) ATE236123T1 (cs)
AU (1) AU740453B2 (cs)
BR (1) BR9810776A (cs)
CA (1) CA2296637C (cs)
CZ (1) CZ296947B6 (cs)
DE (1) DE69812964T2 (cs)
DK (1) DK1000027T3 (cs)
ES (1) ES2195366T3 (cs)
HR (1) HRP980406A2 (cs)
HU (1) HUP0003198A3 (cs)
IL (1) IL133677A (cs)
MA (1) MA26523A1 (cs)
MY (1) MY117734A (cs)
NO (1) NO313588B1 (cs)
NZ (1) NZ502136A (cs)
PE (1) PE96999A1 (cs)
PL (1) PL191602B1 (cs)
PT (1) PT1000027E (cs)
RU (1) RU2202542C2 (cs)
SI (1) SI1000027T1 (cs)
TR (1) TR200000148T2 (cs)
TW (1) TW505631B (cs)
UY (1) UY25108A1 (cs)
WO (1) WO1999005105A1 (cs)
YU (1) YU2200A (cs)
ZA (1) ZA986475B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074356A1 (en) * 2000-04-03 2001-10-11 F. Hoffmann-La Roche Ag Concentrated solutions of carvedilol
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
IL153688A0 (en) 2000-06-28 2003-07-06 Teva Pharma Carvedilol
JP2004534840A (ja) * 2001-07-13 2004-11-18 スミスクライン・ビーチャム・コーポレイション カルベジロール多型体
EP1929998A3 (en) 2001-09-21 2008-11-26 Egalet A/S Controlled release solid dispersions of carvedilol
WO2003029214A1 (en) * 2001-09-28 2003-04-10 F. Hoffmann-La Roche Ag Pseudopolymorphic forms of carvedilol
PL371409A1 (en) 2002-01-15 2005-06-13 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
JP2006500320A (ja) * 2002-04-30 2006-01-05 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール一クエン酸塩一水和物
AU2003251627A1 (en) 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
MXPA04012923A (es) * 2002-06-27 2005-03-31 Sb Pharmco Inc Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
AU2003275953A1 (en) 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
JP2007512372A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
CA2589699A1 (en) * 2004-12-09 2006-06-15 Zach System S.P.A. Process for the preparation of carvedilol and its enantiomers
EP1781611A1 (en) * 2005-06-09 2007-05-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
WO2008002683A2 (en) 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
DE69812964D1 (de) 2003-05-08
YU2200A (sh) 2002-03-18
UY25108A1 (es) 2000-12-29
AU8631998A (en) 1999-02-16
IL133677A (en) 2004-06-01
EP1000027B1 (en) 2003-04-02
RU2202542C2 (ru) 2003-04-20
PT1000027E (pt) 2003-07-31
TR200000148T2 (tr) 2000-07-21
TW505631B (en) 2002-10-11
DE69812964T2 (de) 2004-03-04
ES2195366T3 (es) 2003-12-01
NO313588B1 (no) 2002-10-28
BR9810776A (pt) 2000-09-19
HUP0003198A2 (en) 2001-03-28
HUP0003198A3 (en) 2002-10-28
WO1999005105A1 (en) 1999-02-04
HRP980406A2 (en) 1999-04-30
MA26523A1 (fr) 2004-12-20
JP2001510824A (ja) 2001-08-07
HK1029339A1 (en) 2001-03-30
KR20010022097A (ko) 2001-03-15
CA2296637A1 (en) 1999-02-04
EP0893440A1 (en) 1999-01-27
ZA986475B (en) 2000-01-21
AR015133A1 (es) 2001-04-18
PE96999A1 (es) 1999-10-12
KR100336229B1 (ko) 2002-05-09
NO20000301L (no) 2000-01-21
CN1125047C (zh) 2003-10-22
NZ502136A (en) 2002-05-31
CN1264366A (zh) 2000-08-23
AU740453B2 (en) 2001-11-01
CA2296637C (en) 2005-11-15
NO20000301D0 (no) 2000-01-21
CZ296947B6 (cs) 2006-08-16
PL338432A1 (en) 2000-11-06
SI1000027T1 (en) 2003-10-31
IL133677A0 (en) 2001-04-30
CZ2000221A3 (cs) 2000-05-17
ATE236123T1 (de) 2003-04-15
EP1000027A1 (en) 2000-05-17
MY117734A (en) 2004-07-31
PL191602B1 (pl) 2006-06-30

Similar Documents

Publication Publication Date Title
NO20000301L (no) Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasøytiske blandinger som inneholder den
DK1036794T3 (da) 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
DK1024794T3 (da) Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer
DK1659179T3 (da) Tumor-associerede antigenderivater fra MAGE-familien og nucleinsyresekvenser kodende for dem anvendt til fremstilling af fusionsproteiner og sammensætninger til vaccination
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
DK1412384T3 (da) Stabil formulering af modificeret GLP-1
DK0876131T3 (da) Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener
NO993519L (no) Fenofibrat farmasöytisk blanding som har höy biotilgjengelighet og fremgangsmÕte for fremstilling av den
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
NO20031266D0 (no) Kondenserte heterocykliske suksinimid-forbindelser og analoger derav, modulatorer for nukle¶r hormonreseptorfunksjon
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
NO20015309D0 (no) 1- (P-tienylbenzyl)-imidazoler som antiotensin-(1- 7)reseptoragonister, fremgangsmåte for fremstilling og anvendelseav de samme og farmasöytiske preparater som inneholder nevnteforbindelser
NO984290L (no) Farmas°ytisk nyttige forbindelser
HUP0002425A3 (en) 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
DK1296948T3 (da) N-gamma-krystallinsk form af perindopril-t-butylaminsalt, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dette
HUP0001438A3 (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
DK1089968T3 (da) Thyroideahormonanaloger og fremgangsmåder til deres fremstilling
DK0885204T3 (da) Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
AU9416201A (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
DK1239862T3 (da) Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft
IS6402A (is) Nýjar greinóttar setnar amínó afleiður af 3-amínó-1-fenýl-1H[1,2,4]tríazóli, aðferðir til framleiðslu á þeim og lyfjasamsetningar sem innihalda þær
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler